Adicet Bio (FRA:1IJA) Interest Expense : €-0.01 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Adicet Bio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Adicet Bio's interest expense for the three months ended in Mar. 2024 was € -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Adicet Bio's Operating Income for the three months ended in Mar. 2024 was € -28.40 Mil. Adicet Bio's Interest Expense for the three months ended in Mar. 2024 was € -0.00 Mil. Adicet Bio did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Adicet Bio Interest Expense Historical Data

The historical data trend for Adicet Bio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicet Bio Interest Expense Chart

Adicet Bio Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.11

-0.16

-0.08

-0.02

Adicet Bio Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.02	-	-	-	-

Adicet Bio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01 Mil.

Adicet Bio (FRA:1IJA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Adicet Bio's Interest Expense for the three months ended in Mar. 2024 was €-0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-28.40 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €15.38 Mil.

Adicet Bio's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Adicet Bio did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Adicet Bio (FRA:1IJA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adicet Bio Inc (FRA:1IJA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ACET:USA

Address

200 Clarendon Street, Floor 6, Boston, MA, USA, 02116

Website

https://www.adicetbio.com

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company operates and manages its business as one reportable and operating segment, which is the business of research and development of allogeneic immunotherapies for cancer and other diseases.

Adicet Bio (FRA:1IJA) Headlines

No Headlines